May 6, 2020 / 12:36 PM / 24 days ago

BRIEF-Cassava Sciences Reports First Quarter 2020 Financial Results

May 6 (Reuters) - Cassava Sciences Inc:

* CASSAVA SCIENCES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.05

* AT MARCH 31, 2020, CASH AND CASH EQUIVALENTS WERE $25.6 MILLION

* AT MARCH 31, 2020, CASH AND CASH EQUIVALENTS WERE $25.6 MILLION, COMPARED TO $23.1 MILLION AT DECEMBER 31, 2019, WITH NO DEBT

* NET CASH USE FOR FULL YEAR 2020 IS EXPECTED TO BE APPROXIMATELY $5.0 MILLION

* NET CASH USE FOR FULL YEAR 2020 IS EXPECTED TO BE APPROXIMATELY $5.0 MILLION, CONSISTENT WITH PREVIOUS FINANCIAL GUIDANCE

* COMPANY HAS NOT EXPERIENCED MAJOR DISRUPTIONS ACROSS ITS DRUG MANUFACTURING OPERATIONS OR SUPPLY OF MATERIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below